Beckman Daniella

SVP, CFO and Treasurer at IDENIX PHARMACEUTICALS INC · on record since Mar 2, 2012
Director at Upstream Bio, Inc. · on record since Jun 11, 2026
Director at Vor Biopharma Inc. · on record since Jun 12, 2026
Director at TRANSGENOMIC INC · on record since Jun 27, 2018
Director at 5:01 Acquisition Corp. · on record since Oct 20, 2020
Chief Financial Officer at Tango Therapeutics, Inc. · on record since Aug 16, 2021
Director at Blueprint Medicines Corp · on record since Mar 31, 2022

Insider trading activity of Beckman Daniella

Transactions on record: 60; since Jun 3, 2011

Open-market buys: 0

Open-market sells: 6; $198.7K

Companies traded: 7; last filing Jun 12, 2026

Figures computed from official regulatory filings — methodology.

Companies where Beckman Daniella has traded

Vor Biopharma Inc.6 tx · Jun 12, 2026
Upstream Bio, Inc.3 tx · Jun 11, 2026
Tango Therapeutics, Inc.16 tx · $198.7K · Feb 4, 2026
Blueprint Medicines Corp15 tx · $499.9K · Jul 21, 2025
TRANSGENOMIC INC7 tx · Sep 14, 2021
5:01 Acquisition Corp.1 tx · Oct 20, 2020
IDENIX PHARMACEUTICALS INC12 tx · Aug 5, 2014

Track record of Beckman Daniella

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Beckman Daniella

Co-insiders of Beckman Daniella

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Vor Biopharma Inc.	Jun 12, 2026	AwardD	53,283	0.00 USD	$0	SEC
Upstream Bio, Inc.	Jun 11, 2026	AwardD	17,096	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	Award	44,330	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	Sell	-10,204	12.26 USD	$125.1K	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	Sell	-113	12.90 USD	$1.5K	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	AwardD	265,980	0.00 USD	$0	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-5,300	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	Other	-10,842	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-7,000	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	Other	-3,902	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-4,570	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-5,300	—	—	SEC
Blueprint Medicines Corp	Jun 24, 2025	Award	3,902	128.12 USD	$499.9K	SEC
Upstream Bio, Inc.	Jun 12, 2025	AwardD	17,096	0.00 USD	$0	SEC
Vor Biopharma Inc.	May 23, 2025	AwardD	30,000	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 6, 2025	Sell	-3,948	3.16 USD	$12.5K	SEC
Tango Therapeutics, Inc.	Feb 6, 2025	Sell	-4,284	2.99 USD	$12.8K	SEC
Tango Therapeutics, Inc.	Feb 5, 2025	AwardD	156,713	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 5, 2025	Award	26,119	0.00 USD	$0	SEC
Upstream Bio, Inc.	Oct 15, 2024	AwardD	34,681	0.00 USD	$0	SEC
Blueprint Medicines Corp	Jun 14, 2024	Award	2,242	0.00 USD	$0	SEC
Blueprint Medicines Corp	Jun 14, 2024	AwardD	4,570	0.00 USD	$0	SEC
Vor Biopharma Inc.	May 28, 2024	AwardD	30,000	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 8, 2024	Sell	-1,908	12.56 USD	$24K	SEC
Tango Therapeutics, Inc.	Feb 8, 2024	Sell	-1,817	12.62 USD	$22.9K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Vor Biopharma Inc.	Jun 12, 2026	AwardD	53,283	0.00 USD	$0	SEC
Upstream Bio, Inc.	Jun 11, 2026	AwardD	17,096	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	Award	44,330	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	Sell	-10,204	12.26 USD	$125.1K	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	Sell	-113	12.90 USD	$1.5K	SEC
Tango Therapeutics, Inc.	Feb 4, 2026	AwardD	265,980	0.00 USD	$0	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-5,300	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	Other	-10,842	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-7,000	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	Other	-3,902	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-4,570	—	—	SEC
Blueprint Medicines Corp	Jul 21, 2025	OtherD	-5,300	—	—	SEC
Blueprint Medicines Corp	Jun 24, 2025	Award	3,902	128.12 USD	$499.9K	SEC
Upstream Bio, Inc.	Jun 12, 2025	AwardD	17,096	0.00 USD	$0	SEC
Vor Biopharma Inc.	May 23, 2025	AwardD	30,000	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 6, 2025	Sell	-3,948	3.16 USD	$12.5K	SEC
Tango Therapeutics, Inc.	Feb 6, 2025	Sell	-4,284	2.99 USD	$12.8K	SEC
Tango Therapeutics, Inc.	Feb 5, 2025	AwardD	156,713	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 5, 2025	Award	26,119	0.00 USD	$0	SEC
Upstream Bio, Inc.	Oct 15, 2024	AwardD	34,681	0.00 USD	$0	SEC
Blueprint Medicines Corp	Jun 14, 2024	Award	2,242	0.00 USD	$0	SEC
Blueprint Medicines Corp	Jun 14, 2024	AwardD	4,570	0.00 USD	$0	SEC
Vor Biopharma Inc.	May 28, 2024	AwardD	30,000	0.00 USD	$0	SEC
Tango Therapeutics, Inc.	Feb 8, 2024	Sell	-1,908	12.56 USD	$24K	SEC
Tango Therapeutics, Inc.	Feb 8, 2024	Sell	-1,817	12.62 USD	$22.9K	SEC